🇺🇸 FDA
Pipeline program

Microcrystalline cellulose, GABAPENTINE BIOGARAN 300 mg, gélule

RC-P0103

Approved small_molecule active

Quick answer

Microcrystalline cellulose, GABAPENTINE BIOGARAN 300 mg, gélule for lumbosacral radiculalgia is a Approved program (small_molecule) at Institut für biomedizinische Analytik NMR-Imaging GmbH with 1 ClinicalTrials.gov record(s).

Program details

Company
Institut für biomedizinische Analytik NMR-Imaging GmbH
Indication
lumbosacral radiculalgia
Phase
Approved
Modality
small_molecule
Status
active

Clinical trials